000			01378 a2200385 4500
005			20250513110445.0
264		0	_c19970130
008			199701s 0 0 eng d
022			_a0007-1048
024	7		_a10.1046/j.1365-2141.1996.d01-1951.x _2doi
040			_aNLM _beng _cNLM
100	1		_aMarks, D C
245	0	0	_aExtended multidrug resistance in haemopoietic cells. _h[electronic resource]
260			_bBritish journal of haematology _cDec 1996
300			_a587-95 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism
650	0	4	_aBlotting, Western
650	0	4	_aDrug Resistance, Multiple
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEpirubicin _xtherapeutic use
650	0	4	_aEtoposide _xtherapeutic use
650	0	4	_aHL-60 Cells _xmetabolism
650	0	4	_aHematopoietic Stem Cells _xdrug effects
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid _xdrug therapy
650	0	4	_aPaclitaxel _xtherapeutic use
650	0	4	_aTumor Cells, Cultured
650	0	4	_aVinblastine _xtherapeutic use
700	1		_aSu, G M
700	1		_aDavey, R A
700	1		_aDavey, M W
773	0		_tBritish journal of haematology _gvol. 95 _gno. 4 _gp. 587-95
856	4	0	_uhttps://doi.org/10.1046/j.1365-2141.1996.d01-1951.x _zAvailable from publisher's website
999			_c8973509 _d8973509